Apoptotic Cells Inhibit LPS-Induced Cytokine and Chemokine Production and IFN Responses in Macrophages

Human Immunology

Volumn 68, Issue 3, 2007, Pages 156-164

  Tassiulas, Ioannis ^a   Park Min, Kyung Hyun ^b   Hu, Yang ^a   Kellerman, Lisa ^a   Mevorach, Dror ^c   Ivashkiv, Lionel B ^a,b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Autoimmunity; inflammation; interferon; signaling; STAT

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; STAT PROTEIN; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; AUTOIMMUNE DISEASE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVATION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; CHEMOKINES; CHEMOKINES, CXC; CYTOKINES; DEXAMETHASONE; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; JURKAT CELLS; LIPOPOLYSACCHARIDES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847703719     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.12.008     Document Type: Article

References (32)

1. Fadok V.A., Bratton D.L., and Henson P.M. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 108 (2001) 957
2. Fadok V.A., McDonald P.P., Bratton D.L., and Henson P.M. Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem Soc Trans 26 (1998) 653
3. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101 (1998) 890
4. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., and Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature 390 (1997) 350
5. Savill J., Dransfield I., Gregory C., and Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2 (2002) 965
6. Lu Q., and Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293 (2001) 306
7. Mevorach D., Mascarenhas J.O., Gershov D., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188 (1998) 2313
8. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., and Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 192 (2000) 359
9. Verbovetski I., Bychkov H., Trahtemberg U., Shapira I., Hareuveni M., Ben-Tal O., Kutikov I., Gill O., and Mevorach D. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 196 (2002) 1553
10. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., and Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405 (2000) 85
11. Fadok V.A., Warner M.L., Bratton D.L., and Henson P.M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol 161 (1998) 6250
12. Scott R.S., McMahon E.J., Pop S.M., Reap E.A., Caricchio R., Cohen P.L., Earp H.S., and Matsushima G.K. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411 (2001) 207
13. Gorgani N.N., Smith B.A., Kono D.H., and Theofilopoulos A.N. Histidine-rich glycoprotein binds to DNA and Fc gamma RI and potentiates the ingestion of apoptotic cells by macrophages. J Immunol 169 (2002) 4745
14. Anderson H.A., Maylock C.A., Williams J.A., Paweletz C.P., Shu H., and Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 4 (2003) 87
15. Gershov D., Kim S., Brot N., and Elkon K.B. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192 (2000) 1353
16. van Lent P.L., Licht R., Dijkman H., Holthuysen A.E., Berden J.H., and van den Berg W.B. Uptake of apoptotic leukocytes by synovial lining macrophages inhibits immune complex-mediated arthritis. J Leukoc Biol 70 (2001) 708
17. Huynh M.L., Fadok V.A., and Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109 (2002) 41
18. Bittencourt M.C., Perruche S., Contassot E., Fresnay S., Baron M.H., Angonin R., Aubin F., Herve P., Tiberghien P., and Saas P. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 98 (2001) 224
19. Ivashkiv L.B., and X H. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?. Arthritis Rheum 48 (2003) 2092
20. Theofilopoulos A.N., Koundouris S., Kono D.H., and Lawson B.R. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res 3 (2001) 136
21. Sabroe I., Read R.C., Whyte M.K., Dockrell D.H., Vogel S.N., and Dower S.K. Toll-like receptors in health and disease: complex questions remain. J Immunol 171 (2003) 1630
22. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 (2004) 499
23. Huang Q., Yang J., Lin Y., Walker C., Cheng J., Liu Z.G., and Su B. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Immunol 5 (2004) 98
24. Dumitru C.D., Ceci J.D., Tsatsanis C., Kontoyiannis D., Stamatakis K., Lin J.H., Patriotis C., Jenkins N.A., Copeland N.G., Kollias G., and Tsichlis P.N. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103 (2000) 1071
25. Lee I.H., Li W.P., Hisert K.B., and Ivashkiv L.B. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion. J Exp Med 19 (1999) 1263
26. Chen W., Frank M.E., Jin W., and Wahl S.M. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14 (2001) 715
27. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., and Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167 (2001) 5887
28. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., and Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143
29. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., and Akira S. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int Immunol 14 (2002) 1225
30. Savill J., and Fadok V. Corpse clearance defines the meaning of cell death. Nature 407 (2000) 784
31. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., and Luster A.D. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168 (2002) 3195
32. Yasukawa H., Sasaki A., and Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 18 (2000) 143